Biological evaluation and structure-activity relationships of imidazole-based compounds as antiprotozoal agents. 2018

Francesco Saccoliti, and Valentina Noemi Madia, and Valeria Tudino, and Alessandro De Leo, and Luca Pescatori, and Antonella Messore, and Daniela De Vita, and Luigi Scipione, and Reto Brun, and Marcel Kaiser, and Pascal Mäser, and Claudia Magalhaes Calvet, and Gareth K Jennings, and Larissa M Podust, and Roberta Costi, and Roberto Di Santo
Istituto Pasteur-Fondazione Cenci Bolognetti, Dipartimento di Chimica e Tecnologie del Farmaco, "Sapienza" Università di Roma, p.le Aldo Moro 5, I-00185, Rome, Italy. Electronic address: francesco.saccoliti@uniroma1.it.

We discovered a series of azole antifungal compounds as effective antiprotozoal agents. They displayed promising inhibitory activities within the micromolar-submicromolar range against P. falciparum, L. donovani, and T. b. rhodesiense. Moreover, most of such compounds showed excellent nanomolar IC50 against T. cruzi, showing also very low cytotoxicity. Discussion of structure-activity relationships and biological data for these compounds are provided against the different parasites. To assess the mechanism of action against T. cruzi we proved that the most potent compounds (3b, 3j-l) inhibited the T. cruzi CYP51. Moreover, the most active derivative 3j dramatically reduced parasitemia in T. cruzi mouse model without acute toxicity.

UI MeSH Term Description Entries
D007093 Imidazoles Compounds containing 1,3-diazole, a five membered aromatic ring containing two nitrogen atoms separated by one of the carbons. Chemically reduced ones include IMIDAZOLINES and IMIDAZOLIDINES. Distinguish from 1,2-diazole (PYRAZOLES).
D007893 Leishmania donovani A parasitic hemoflagellate of the subgenus Leishmania leishmania that infects man and animals and causes visceral leishmaniasis (LEISHMANIASIS, VISCERAL). The sandfly genera Phlebotomus and Lutzomyia are the vectors. Leishmania (Leishmania) donovani,Leishmania leishmania donovani,Leishmania donovanus,Leishmania leishmania donovanus,donovani, Leishmania leishmania,donovanus, Leishmania,donovanus, Leishmania leishmania,leishmania donovanus, Leishmania
D007898 Leishmaniasis, Visceral A chronic disease caused by LEISHMANIA DONOVANI and transmitted by the bite of several sandflies of the genera Phlebotomus and Lutzomyia. It is commonly characterized by fever, chills, vomiting, anemia, hepatosplenomegaly, leukopenia, hypergammaglobulinemia, emaciation, and an earth-gray color of the skin. The disease is classified into three main types according to geographic distribution: Indian, Mediterranean (or infantile), and African. Black Fever,Kala-Azar,Fever, Black,Kala Azar,Visceral Leishmaniasis
D008807 Mice, Inbred BALB C An inbred strain of mouse that is widely used in IMMUNOLOGY studies and cancer research. BALB C Mice, Inbred,BALB C Mouse, Inbred,Inbred BALB C Mice,Inbred BALB C Mouse,Mice, BALB C,Mouse, BALB C,Mouse, Inbred BALB C,BALB C Mice,BALB C Mouse
D010963 Plasmodium falciparum A species of protozoa that is the causal agent of falciparum malaria (MALARIA, FALCIPARUM). It is most prevalent in the tropics and subtropics. Plasmodium falciparums,falciparums, Plasmodium
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000981 Antiprotozoal Agents Substances that are destructive to protozoans. Schizonticides,Agents, Antiprotozoal

Related Publications

Francesco Saccoliti, and Valentina Noemi Madia, and Valeria Tudino, and Alessandro De Leo, and Luca Pescatori, and Antonella Messore, and Daniela De Vita, and Luigi Scipione, and Reto Brun, and Marcel Kaiser, and Pascal Mäser, and Claudia Magalhaes Calvet, and Gareth K Jennings, and Larissa M Podust, and Roberta Costi, and Roberto Di Santo
January 2020, ChemMedChem,
Francesco Saccoliti, and Valentina Noemi Madia, and Valeria Tudino, and Alessandro De Leo, and Luca Pescatori, and Antonella Messore, and Daniela De Vita, and Luigi Scipione, and Reto Brun, and Marcel Kaiser, and Pascal Mäser, and Claudia Magalhaes Calvet, and Gareth K Jennings, and Larissa M Podust, and Roberta Costi, and Roberto Di Santo
September 2013, Journal of medicinal chemistry,
Francesco Saccoliti, and Valentina Noemi Madia, and Valeria Tudino, and Alessandro De Leo, and Luca Pescatori, and Antonella Messore, and Daniela De Vita, and Luigi Scipione, and Reto Brun, and Marcel Kaiser, and Pascal Mäser, and Claudia Magalhaes Calvet, and Gareth K Jennings, and Larissa M Podust, and Roberta Costi, and Roberto Di Santo
December 1968, The Journal of pharmacology and experimental therapeutics,
Francesco Saccoliti, and Valentina Noemi Madia, and Valeria Tudino, and Alessandro De Leo, and Luca Pescatori, and Antonella Messore, and Daniela De Vita, and Luigi Scipione, and Reto Brun, and Marcel Kaiser, and Pascal Mäser, and Claudia Magalhaes Calvet, and Gareth K Jennings, and Larissa M Podust, and Roberta Costi, and Roberto Di Santo
March 2008, Bioorganic & medicinal chemistry,
Francesco Saccoliti, and Valentina Noemi Madia, and Valeria Tudino, and Alessandro De Leo, and Luca Pescatori, and Antonella Messore, and Daniela De Vita, and Luigi Scipione, and Reto Brun, and Marcel Kaiser, and Pascal Mäser, and Claudia Magalhaes Calvet, and Gareth K Jennings, and Larissa M Podust, and Roberta Costi, and Roberto Di Santo
April 2022, Bioorganic chemistry,
Francesco Saccoliti, and Valentina Noemi Madia, and Valeria Tudino, and Alessandro De Leo, and Luca Pescatori, and Antonella Messore, and Daniela De Vita, and Luigi Scipione, and Reto Brun, and Marcel Kaiser, and Pascal Mäser, and Claudia Magalhaes Calvet, and Gareth K Jennings, and Larissa M Podust, and Roberta Costi, and Roberto Di Santo
January 2019, European journal of medicinal chemistry,
Francesco Saccoliti, and Valentina Noemi Madia, and Valeria Tudino, and Alessandro De Leo, and Luca Pescatori, and Antonella Messore, and Daniela De Vita, and Luigi Scipione, and Reto Brun, and Marcel Kaiser, and Pascal Mäser, and Claudia Magalhaes Calvet, and Gareth K Jennings, and Larissa M Podust, and Roberta Costi, and Roberto Di Santo
May 2007, Bioorganic & medicinal chemistry,
Francesco Saccoliti, and Valentina Noemi Madia, and Valeria Tudino, and Alessandro De Leo, and Luca Pescatori, and Antonella Messore, and Daniela De Vita, and Luigi Scipione, and Reto Brun, and Marcel Kaiser, and Pascal Mäser, and Claudia Magalhaes Calvet, and Gareth K Jennings, and Larissa M Podust, and Roberta Costi, and Roberto Di Santo
March 2011, European journal of medicinal chemistry,
Francesco Saccoliti, and Valentina Noemi Madia, and Valeria Tudino, and Alessandro De Leo, and Luca Pescatori, and Antonella Messore, and Daniela De Vita, and Luigi Scipione, and Reto Brun, and Marcel Kaiser, and Pascal Mäser, and Claudia Magalhaes Calvet, and Gareth K Jennings, and Larissa M Podust, and Roberta Costi, and Roberto Di Santo
April 2009, Journal of medicinal chemistry,
Francesco Saccoliti, and Valentina Noemi Madia, and Valeria Tudino, and Alessandro De Leo, and Luca Pescatori, and Antonella Messore, and Daniela De Vita, and Luigi Scipione, and Reto Brun, and Marcel Kaiser, and Pascal Mäser, and Claudia Magalhaes Calvet, and Gareth K Jennings, and Larissa M Podust, and Roberta Costi, and Roberto Di Santo
August 1995, Drug design and discovery,
Copied contents to your clipboard!